Perspective of Targeting Cancer-Associated Fibroblasts in Melanoma

Melanoma is known as an exceptionally aggressive and treatment-resistant human cancer. Although a great deal of progress has been made in the past decade, including the development of immunotherapy using immune checkpoint inhibitors and targeted therapy using BRAF, MEK or KIT inhibitors, treatment f...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Linli, Yang, Kun, Andl, Thomas, Wickett, R. Randall, Zhang, Yuhang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504107/
https://www.ncbi.nlm.nih.gov/pubmed/26185533
http://dx.doi.org/10.7150/jca.10865

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504107/
https://www.ncbi.nlm.nih.gov/pubmed/26185533
http://dx.doi.org/10.7150/jca.10865

Ejemplares similares